Clinical Trial

Cocaine, Nasal Oxytocin, and Maternal Psychophysiology

Study Description

Prenatal Cocaine, Nasal Oxytocin, and Maternal Psychophysiology

The purpose of this research is to study the effects of nasal oxytocin administration on maternal behaviors that may be influenced by cocaine use during pregnancy. 32 mothers with prenatal use of cocaine during the current pregnancy will be studied at 3-6 months postpartum, when they will complete 3 study visits, a 2-week double-blind trial of twice daily nasal spray (oxytocin or placebo) and 4 telephone interviews. All information collected is confidential.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Syntocinon treatment

24 IU twice daily (A single dose will be delivered consisting of 6 intranasal insufflations (3 in each nostril) which is equivalent to a total of 24 international units (IU) of oxytocin twice daily).

Placebo

Placebo nasal spray vials will contain the same ingredients in the nasal preparation, but without oxytocin.

Additional Information

Official Study Title

Prenatal Cocaine, Nasal Oxytocin, and Maternal Psychophysiology

Clinical Trial ID

NCT02872467

ParticipAid ID

kaz5ye